In another study performed on the cerebrospinal fluid (CSF) from patients with mild cognitive impairment and AD, the presence of both polymorphic alleles for NFE2L2 and KEAP1 and pro-inflammatory markers was analyzed. This evidence concerns the gene NFE2L2 and Alzheimer disease.